Leerink Partnrs Has Optimistic Outlook of THC Q3 Earnings

Tenet Healthcare Co. (NYSE:THC) – Investment analysts at Leerink Partnrs lifted their Q3 2025 earnings per share estimates for shares of Tenet Healthcare in a note issued to investors on Tuesday, June 3rd. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings of $2.28 per share for the quarter, up from their prior estimate of $2.17. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Leerink Partnrs also issued estimates for Tenet Healthcare’s Q4 2025 earnings at $3.02 EPS, Q3 2026 earnings at $2.91 EPS, Q4 2026 earnings at $3.69 EPS, FY2026 earnings at $13.98 EPS and FY2027 earnings at $17.19 EPS.

Several other equities analysts have also weighed in on the company. TD Cowen assumed coverage on Tenet Healthcare in a research note on Wednesday, February 26th. They issued a “buy” rating and a $175.00 price target for the company. Baird R W lowered Tenet Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 15th. UBS Group boosted their price objective on Tenet Healthcare from $217.00 to $230.00 and gave the stock a “buy” rating in a research note on Wednesday, April 30th. Guggenheim assumed coverage on Tenet Healthcare in a research note on Wednesday, April 9th. They set a “buy” rating and a $165.00 price objective for the company. Finally, The Goldman Sachs Group boosted their price objective on Tenet Healthcare from $134.00 to $154.00 and gave the stock a “neutral” rating in a research note on Monday, May 5th. Three research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $180.18.

Tenet Healthcare Price Performance

Shares of Tenet Healthcare stock opened at $171.36 on Friday. The company has a quick ratio of 1.70, a current ratio of 1.78 and a debt-to-equity ratio of 2.25. Tenet Healthcare has a twelve month low of $109.82 and a twelve month high of $174.14. The business has a 50-day moving average price of $144.43 and a 200 day moving average price of $137.09. The firm has a market cap of $15.92 billion, a PE ratio of 5.32, a P/E/G ratio of 1.02 and a beta of 1.65.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $4.36 earnings per share for the quarter, beating the consensus estimate of $3.11 by $1.25. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%. The firm had revenue of $5.22 billion during the quarter, compared to analyst estimates of $5.15 billion. During the same quarter in the previous year, the business earned $3.22 EPS. Tenet Healthcare’s revenue for the quarter was down 2.5% compared to the same quarter last year.

Insider Buying and Selling

In related news, Director J Robert Kerrey sold 5,001 shares of the stock in a transaction that occurred on Friday, May 9th. The stock was sold at an average price of $148.50, for a total value of $742,648.50. Following the completion of the transaction, the director now directly owns 22,377 shares in the company, valued at approximately $3,322,984.50. This represents a 18.27% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director James L. Bierman sold 13,836 shares of the company’s stock in a transaction on Friday, May 23rd. The stock was sold at an average price of $159.58, for a total value of $2,207,948.88. Following the transaction, the director now owns 41,435 shares in the company, valued at $6,612,197.30. This trade represents a 25.03% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 63,646 shares of company stock worth $10,041,025. Company insiders own 0.81% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the company. US Bancorp DE raised its stake in shares of Tenet Healthcare by 0.8% in the first quarter. US Bancorp DE now owns 8,620 shares of the company’s stock valued at $1,159,000 after acquiring an additional 68 shares in the last quarter. Lindbrook Capital LLC raised its stake in shares of Tenet Healthcare by 5.3% in the first quarter. Lindbrook Capital LLC now owns 1,427 shares of the company’s stock valued at $192,000 after acquiring an additional 72 shares in the last quarter. EverSource Wealth Advisors LLC raised its stake in shares of Tenet Healthcare by 9.3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 940 shares of the company’s stock valued at $119,000 after acquiring an additional 80 shares in the last quarter. Covestor Ltd raised its stake in shares of Tenet Healthcare by 10.4% in the first quarter. Covestor Ltd now owns 873 shares of the company’s stock valued at $117,000 after acquiring an additional 82 shares in the last quarter. Finally, GeoWealth Management LLC raised its stake in shares of Tenet Healthcare by 39.8% in the fourth quarter. GeoWealth Management LLC now owns 295 shares of the company’s stock valued at $37,000 after acquiring an additional 84 shares in the last quarter. 95.44% of the stock is currently owned by institutional investors and hedge funds.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.